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Abstract: A current aim of nutrigenetics is to personalize nutritional practices according to 
genetic variations that influence the way of digestion and metabolism of nutrients 
introduced with the diet. Nutritional epigenetics concerns knowledge about the effects of 
nutrients on gene expression. Nutrition in early life or in critical periods of development, 
may have a role in modulating gene expression, and, therefore, have later effects on health. 
Human breast milk is well-known for its ability in preventing several acute and chronic 
diseases. Indeed, breastfed children may have lower risk of neonatal necrotizing 
enterocolitis, infectious diseases, and also of non-communicable diseases, such as obesity 
and related-disorders. Beneficial effects of human breast milk on health may be associated 
in part with its peculiar components, possible also via epigenetic processes. This paper 
discusses about presumed epigenetic effects of human breast milk and components. While 
evidence suggests that a direct relationship may exist of some components of human breast 
milk with epigenetic changes, the mechanisms involved are still unclear. Studies have to be 
conducted to clarify the actual role of human breast milk on genetic expression, in 
particular when linked to the risk of non-communicable diseases, to potentially benefit the 
infant’s health and his later life. 
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1. Introduction 
1.1. Beneficial Effects of Human Breast Milk 
Breastfeeding and human milk are the normative standards for infant feeding and nutrition.  
Short-and long-term benefits of breastfeeding on health are documented [1,2]. Breastfeeding has been 
associated with a reduction in the incidence of gastrointestinal tract infections, respiratory tract 
infections, and otitis media [1,2]. The relationship of human milk feeding with a significant reduction 
in the incidence of necrotizing enterocolitis (NEC) has been suggested in preterm infants [3]. 
Protective effects are shown also in autoimmune disorders (celiac disease, type-1 diabetes) and 
inflammatory bowel disease [1,2]. Additionally there is extensive evidence that individuals who had 
been breast-fed or received human milk show lower risk of some non-communicable diseases in later 
life [1,2]. Indeed breastfeeding has been associated with lower risk of obesity, lower levels of arterial 
blood pressure, lower total-and LDL-blood cholesterol levels in adulthood, and lower risk of 
developing type-2 diabetes [1,2]. Furthermore consistent differences in neurodevelopmental outcome 
between breastfed and formula fed infants have been reported [1,2]. Evidence about the association 
between neurodevelopment and exclusive breastfeeding was provided by the cluster-randomized 
Promotion of Breastfeeding Intervention Trial (PROBIT) study [4]. Adjusted outcomes of intelligence 
scores were significantly greater in exclusively breastfed for three months or longer. 
Human milk consists not only of nutrients, but also of biologically active compounds, which may 
play an important role in the health benefits associated with breast-feeding [1]. For example nutrition is 
one of many factors that affect brain development not only morphologically, but also for 
neurochemistry and neurophysiology. The NUTRIMENTHE (The Effect of Diet on the Mental 
Performance of Children) is a large collaborative European Project assessing the short- and long-term 
effects of specific nutrients and food components in early-post-natal diet on neurodevelopment through 
well-designed large-scale epidemiological studies [5]. The fatty acids provided in breast milk are 
thought to play a crucial role in this respect. Indeed, a recent review indicated that neurodevelopment 
and cognitive abilities may be enhanced by early provision of n-3 long-chain polyunsaturated fatty 
acids (LCPUFAs) through breast milk or docosahexaenoic acid (DHA)-fortified foods may improve 
neurodevelopment and cognitive abilities [6]. 
However nutrients should not be considered only as an energy source or as factors involved in the 
development of the organism. More recently molecular biology studies have shown that nutrients, 
either directly or by hormonal activity, are able to significantly influence the expression of genes [7]. 
Through the nutrigenomics it may be possible to identify mechanisms that underline individual 
variations in dietary requirements, as well as in the capacity to respond to food-based interventions [7].
 
In this way nutrigenomics may be able to provide personalized nutrition recommendations in order to 
improve the prevention and therapy of pathologies in which each would be predisposed [8]. The 
research, aimed to analyzing the influence of nutrients on health through nutrigenomics, find their 
basis on two observations:  
1. The diet changes the gene expression (nutritional epigenetics). 
2. The metabolic processes of nutrients may vary and affect the state of health depending on the 
individual genotype (nutrigenetics). 
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Nutrigenetics, a fundamental branch of nutrigenomics, has the purpose to identify the genetic 
variations influencing the way of digestion and metabolism of molecules introduced in the diet [9]. 
The analysis of the Single Nucleotide Polymorphisms (SNPs) has identified genetic variations linked 
to the risk of each individual. SNPs, single base-pair differences in DNA sequence, represent a primary 
form of human genetic variation. The presence of differences in genetic material due to a single 
nucleotide may explain not only the onset of certain pathological conditions, but also the different 
responses to nutrients/foods in the diet [10]. An example of application of the concepts of nutrigenetics 
concerns the relationship between the apolipoprotein E gene polymorphism and the diet. The subjects 
with the apoE gene promoter (−219G/T) polymorphism show higher levels of LDL cholesterol and 
apoB plasma concentrations after consuming a saturated fatty acids rich diet [11]. Therefore, the 
219G/T polymorphism may partly explain the individual differences in response to the diet introducing 
the possibility of prevention of hypercholesterolemia and its complications consuming a saturated fatty 
acids poor diet in individuals with this particular genotype [11]. 
Current nutrition recommendations are based on estimated average nutrient requirements for a 
target population and aim to meet the needs of most individuals within a population but also to prevent 
non-communicable diseases [12]. In the case of specific genetic polymorphisms, personalized nutrition 
recommendations may be needed [13]. Nutrigenetics is a promising tool that may be important  
to refine current nutrition recommendations and to provide personalized recommendations in  
population subgroups. 
1.2. Nutritional Epigenetics 
If evidence suggests that genome may be able to influence the nutrition [9], nutrients may be able to 
regulate gene expression [14]. Genes and nutrition seem, therefore, to be in mutual relationship. The 
term epigenetics literally means on top of genetics and refers to processes that induce heritable changes 
in gene expression without altering the gene sequence [10]. Epigenetic processes are integral in 
determining when and where specific genes are expressed. Alterations in the epigenetic regulation of 
genes may lead to profound changes in phenotype. The major epigenetic processes are DNA 
methylation, histone modification, chromatin remodeling and microRNAs, although it is still debated if 
miRNA may be considered as an epigenetic phenomenon. To date, most studies on the effect of  
early-life nutrition on the epigenetic regulation of genes have focused on DNA methylation [15–18]. 
Methylation of the 5′ position of a cytosine within the genome occurs by the enzymatic family of DNA 
methyltransferases forming 5-methylcytosine (5-mC), that is present in an estimated 4%–6% of the 
cytosine bases within a human genome. Most of DNA methylation occurs within CpG dinucleotides, 
although methylation outside of the CpG context has been reported in human DNA in recent  
years [18]. The human genome contains about 30 million CpG dinucleotides that exist in a methylated 
or unmethylated state. Dense repeats of CpG nucleotides are called CpG islands and occur throughout 
the genome. Methylation of CpG islands located in the promoter region of a gene is usually inversely 
associated with transcription of that gene due to binding of methyl-CpG binding proteins, which recruit 
proteins to the promoter of the gene, thereby blocking transcription. Therefore, epigenetics, that is the 
inter-individual variation in DNA methylation patterns and chromatin remodeling, provide a potential 
explanation for how environmental factors (e.g., bioactive food components, nutrients, specific diets) 
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can modify the risk for development of many common diseases [16,17]. Age, genetics, and 
environment may together interact to affect epigenetic regulation. The epigenetics determinants may 
interfere at any time during the life of the individual [18]. Several studies have shown that the 
environment and nutrition, at an early stage or at critical periods of development, may influence the 
expression of genes with short- and long-term effects on the organism [15–17]. 
Data obtained from animal models suggest that maternal malnutrition during pregnancy results in a 
retardation of growth but also in a modification of the expression of biochemical mechanisms related 
to the endocrinological and metabolic control [15]. Indeed, it has been showed that offspring of 
mothers in a protein-restricted diet, from conception throughout pregnancy, present an altered 
metabolic phenotype showing a number of features of human cardio-metabolic disease, including 
hypertension, increased fat deposition, impaired glucose homeostasis, dyslipidaemia and vascular 
dysfunction [16]. In rats, maternal protein-restriction seems to epigenetically program metabolism in 
the offspring. In pups whose mothers were fed a diet low in protein was observed a reduced 
methylation and increased expression of peroxisome proliferator-activated receptor a (PPARα) in the 
liver [18]. Similar results were seen for the glucocorticoid receptor gene [18]. More recently, a low 
protein maternal diets in pigs was shown to effect global DNA methylation in the newborn offspring 
through changes in DNA methyltransferase (Dnmt1, Dnmt2 and Dnmt3) expression in both the liver 
and skeletal muscle [18]. These findings may demonstrate the influence of the maternal diet on the 
pup’s fat and carbohydrate metabolism. 
Human studies found that adult disease risk may be associated with adverse environmental 
conditions early in development. In particular, the risk of obesity and its associated conditions may be 
related to the timing of nutrient constraint during pregnancy [19]. Several studies, focused on 
individuals exposed to famine in utero which occurred in the Netherlands during the winter of 1944, 
presented evidences that individuals whose mothers were exposed to famine periconceptually and in 
the first trimester of pregnancy showed low birth weight compared with unexposed individuals and, as 
adults, exhibited increased risk of obesity and cardiovascular disease [20]. In addition, nutrition in 
early postnatal life may affect susceptibility to future obesity [21]. Early catch up growth in infants 
born preterm, who also have a reduced fat mass at birth, and who were formula fed show increased 
risk of cardio-metabolic disease in later life, including obesity [21]. The exact mechanisms underlying 
how early nutrition may cause programming of risk of non-communicable diseases are unknown, but 
are thought to be associated with altered development of organ structure or persistent alteration at 
cellular level [22]. Among proposed mechanisms, acute or persistently altered gene expression through 
a variety of epigenetic pathways may be included [22]. During in utero or early postnatal development, 
short-term changes through environmental influences could permanently change organ development at 
a time of extreme vulnerability or ―plasticity‖ [22]. A recent study is the first example of an 
association between periconceptional exposure to environmental factors and DNA methylation in 
humans [20]. Individuals who were prenatally exposed to famine during the Dutch Hunger Winter had, 
six decades later, showed less DNA methylation of the imprinted Insulin Growth Factor (IGF) 2 gene 
compared with unexposed, same-sex siblings. The association was specific for periconceptional 
exposure, reinforcing that very early mammalian development is a crucial period for establishing and 
maintaining epigenetic marks [20]. Changes in epigenetic marks as differences in methylation of the 
IGF2 DMR (differentially methylated region) could affect the phenotypic expression and be associated 
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with an increased risk of adult disease considering that IGF2 is a key factor in human growth and 
development [20]. 
These findings demonstrate that the prenatal and early postnatal periods have a critical role in the 
individual outcome, as Barker affirms: ―Much of human development is completed during the first 
1000 days after conception‖ [21]. At least epigenetics might partially explain the mechanism that 
delucidates the fetal ―programming‖ [16,17]. 
1.3. Topic of Review 
While beneficial effects of human breast milk on health have been recognized, it is, nowadays, 
debatable whether these effects may be mediated and/or linked with epigenetic processes. The aim of 
this paper is to discuss on this topic with respect to current evidence investigating the role of human 
breast milk and components in controlling epigenetic changes. 
2. Epigenetic Effects of Human Breast Milk 
Breast milk, with nutritional but also functional components, is a real biological system. According 
to present knowledge, it is associated not only with improved parameters of growth, but also with a 
better neuronal-behavioral development [1,23]. It is also associated with the prevention of some 
communicable and non-communicable diseases [1,2]. The source of these health beneficial effects may 
be the peculiar composition of breast milk, partly explained by epigenetic processes. Indeed, the 
relationship between nutrition in early life and genome may allow to understand the underlying 
mechanisms of disease that have high impact on individual health. 
2.1. Neonatal Necrotizing Enterocolitis 
Neonatal Necrotizing Enterocolitis (NEC) is a severe intestinal inflammatory disorder in newborns. 
Although the pathogenesis is not completely understood, NEC may be associated with an inappropriate 
innate immune and excessive inflammatory response of the immature intestine. It has been reported in 
several studies that the incidence of NEC was higher in formula-fed than in breastfed babies [24]. 
Recently, breastfeeding has been associated to 77% reduction risk in preterm infants compared to 
formula [1]. One explanation for the reduced incidence of NEC in infants fed with human milk is the 
enhanced production of secretory IgA (sIgA) in human milk feeding [25] that provides protection 
against pathogenic organisms. Indeed deficient IgA production in preterm neonates may facilitate 
bacterial translocation across the intestinal mucosa. Moreover, breast milk provides a multitude of 
proteins with anti-inflammatory properties, according to both in vitro and in vivo studies, such as  
anti-inflammatory cytokines (e.g., TGF β, transforming growth factor beta) [26]. However, an 
inappropriate and early alteration in composition of gut microbiota or an unfavorable balance between 
commensal and pathogenic bacteria (dysbiosis) has been strongly involved in the pathogenesis of  
NEC [25,27]. Full-term, vaginally born infants are completely colonized with a diverse array of 
bacterial families by the first year of life. The type of oral feeding (e.g., breast vs. formula feeding) 
may strongly influence short-term composition of infant’s gut microbiota [28]. At six months, weaning 
to a solid diet leads to complete colonization and the infants have a unique signature of microbiota 
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with them throughout their lifetime. Appropriate colonization is influenced by the prebiotic effect of 
breast milk oligosaccharides. Breast milk has a large percentage of undigestible oligosaccharides  
(e.g., 8% of total calories), which function as prebiotics, providing substrate for the production of 
short-chain fatty acids, leading to the proliferation of health-promoting bacteria, such as Bifidobacteria 
and Lactobacillus. An association between the levels of secretory IgA in intestinal secretions and the 
number of Bifidobacteria in the gut at one month of age has been showed [29]. Therefore, human 
breast milk may have a role in preventing NEC with programming sIgA excretion through the 
influence on gut microbiota composition. Additionally, commensal bacteria may regulate the 
expression of genes important for barrier function, digestion, and angiogenesis. In vitro studies it has 
been demonstrated that many species of commensal bacteria may reduce the inflammatory response by 
inhibiting the nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) [25]. This is very 
important considering that the balance of pro- and anti-inflammatory signaling is critical in 
maintaining normal intestinal functions. Moreover, it has been found in vitro that human breast milk 
suppresses the interleukine (IL) 1-β-induced activation of the IL-8 gene promoter in human intestinal 
cells by inhibiting the activation of NF-κB [30]. Some investigations on the immunomodulatory role of 
human breast milk through regulation of gene expression lead to lactoferrin properties, an abundant 
breast milk protein [31]. Lactoferrin is able to bind proinflammatory bacterial DNA sequence (CpG 
motifs) in extracellular compartments and this binding seems to inhibit the CpG- motif DNA-induced 
activation of NF-κB-regulated genes, such as IL-8 and IL-12 in B cells [31]. Bacterial DNA CpG 
motifs may be present in the lamina propria and Peyer’s patches due to lysis of entheropathogens, and 
human milk lactoferrin may modulate immune responses concerning to lymphoid follicles of the infant 
intestine [31]. 
In conclusion results from literature suggest a possible direct and/or gut microbiota programming 
mediated epigenetics role of human breast milk in preventing preterm infants’ NEC by suppressing  
the NF-κB signaling pathway involved in the regulation of proinflammatory cytokines genes,  
as Interleukin-8. 
2.2. Infectious Diseases and Disorders of the Immune System 
The preventive effect on infections is one of the most important health benefits in relation to 
breastfeeding [1,2]. Breastfeeding is strictly associated with a lower risk of gastrointestinal infections 
and of acute otitis media [1,2]. Important breast milk components may influence infection 
susceptibility, such as anti-inflammatory cytokines and pathogen neutralizing secrectory IgA 
antibodies [26]. Recently, proinflammatory cytokine gene polymorphisms, such as TNF-α and 
Interleukin-6 gene polymorphisms (TNF-α−308 and IL-6−174), have been associated with increased risk 
for otitis media (OM) susceptibility [32]. Breastfeeding may protect against OM even when children 
are carriers of TNF-α−308 and IL-6−174 polymorphisms stressing the evidence that environmental factors, 
such as breastfeeding, may help to reduce occurrence of diseases also in genetically susceptible 
subjects [32]. 
Breastfeeding is associated with a reduction in the risk of childhood inflammatory bowel disease 
and of celiac disease of 31% and 52%, respectively, in infants who were exclusively breastfed at the 
time of gluten exposure [1]. This protective role may result from the interaction of immunomodulating 
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effect of human milk and the underlying genetic susceptibility of the infant. In addition, the different 
patterns of gut microbiota composition in breastfed versus formula fed infants may be linked to the 
preventive effect of human milk, taking into account that gut microbiota may have a role in 
programming the immune phenotype [33,34]. As for NEC, the epigenetic role of human breast milk in 
preventing infectious diseases and disorders of immune phenotype, direct and/or gut microbiota 
mediated, may be linked to the expression regulation of proinflammatory cytokines genes. 
2.3. Obesity and Related-Disorders 
Breastfeeding, compared with formula feeding, has been associated with lower risk of being obese, 
lower risk of developing type-2 diabetes, lower total cholesterol and lower levels of arterial blood 
pressure [1,2]. The plausible mechanisms by which breast-feeding may show a protective role could be 
the nutrients composition of breast milk and a peculiar feeding behavior associated to breastfeeding. 
Indeed, lower protein and energy content in breast milk than formula, jointly with higher content of 
LCPUFA, cholesterol and non-digestible carbohydrate (substrate for beneficial strains, 
Bifidobacterium and Lactobacillus spp., growing in gut microbiota) may act synergistically, 
additionally with better hunger and satiety self-regulate of breast-fed infants (possibly modulated by 
some hormones and hormone-like compound, e.g., ghrelin and leptin), to determine healthier  
outcomes [35]. 
The risk of developing obesity depends on the interaction between genotype and individual 
lifestyles, and also environment and nutrition during fetal life and in the early ages of life are very 
important [19–21]. The epigenetic regulation of specific genes may also become crucial in determining 
the individual risk for obesity. The peroxisome proliferator-activated receptor-γ (PPARγ2) 
transcription factor is primarily expressed in adipocytes [36]. It is a member of the nuclear hormone 
receptor family, influencing whole body energy homeostasis via three main metabolic pathways: 
adipocyte differentiation, insulin sensitivity, and lipoprotein metabolism [36]. Out of several variants 
identified in the PPARγ2 gene, the most common is the Pro12Ala substitution at codon 12 [37–39]. 
This polymorphism has been shown to be associated with reduced ability to transactivate responsive 
promoters and, in adults, with higher BMI, waist circumference, and obesity risk [37–39]. In a recent 
study the PPARγ Ala12 allele was associated with higher adiposity indexes (BMI, waist 
circumference, and the sum of skinfolds) in adolescent who had not been breast-fed [40]. However, 
this association was not seen in Ala 12 carriers who had been breast-fed (even for a short period). This 
result may suggest both that breastfeeding may have beneficial effect on the obesity risk later in life in 
genetically predisposed groups [40] both that breast milk may have an epigenetic effect associated to 
the adiposity and related-disorders development. Indeed, it has been described that breast milk supplies 
factors, such as prostaglandin J2, arachidonic acid derivative, natural PPARγ ligand [40]. The decrease 
in PPARγ2 transcriptional activity observed in Ala12 allele carries could be, therefore, compensated 
for by breast milk. In experimental studies PPAR-γ expression has been considered important also in 
reducing liver fibrogenesis [41]. Indeed, in nonalcoholic fatty liver disease (NAFLD), an  
obesity-related disorders, PPAR-γ expression has been suggested as possible target of therapeutic 
approachs [42]. Recently, some authors have hypothesized a beneficial effect of breastfeeding duration 
on progression of NAFLD, particularly on non-alcoholic steatohepatitis (NASH) and liver  
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fibrosis [43]. In addition, for this protective role of breastfeeding may be considered an epigenetic 
mechanism. Long-chain polyunsaturated fatty acids of the n-3 series, especially DHA could act as 
activators of PPAR (α and γ) implicated in protection against fibrosis [42]. DHA enriched diet has 
been found to reduce the risk of liver steatosis in animals by down-regulating the liver lipogenic and 
cholesterol biosynthesis [44]. 
The possibility that early infant feeding has long-term effects on blood cholesterol levels is 
supported by many studies [1,2]. Breastfeeding seems to be associated with increased mean total 
cholesterol and LDL cholesterol levels in infancy but lower levels in adulthood [45,46]. Dietary 
cholesterol intake seems to be the main determinant of total cholesterol level in infancy [46]. The high 
cholesterol content of breast milk may well be responsible. High cholesterol intake in infancy may 
reduces endogenous cholesterol synthesis, probably by down-regulation of hepatic hydroxymethyl 
glutaryl coenzyme A (HMGCoA) reductase [45,46]. Additionally it has been showed that  
n-3 LCPUFA may modulate the HMGCoA reductase expression in rats [47]. This epigenetic 
mechanism, high cholesterol content in breast milk and down-regulation of HMGCoA reductase, 
might be further studied. 
Moreover the contribution of the gut microbiota, such as dysbiosis, to the development of obesity 
and obesity-related disorders, including diabetes, atherosclerosis, and NAFLD, is becoming  
clear [48,49], even if more studies are needed. From this view point the beneficial effects of 
breastfeeding on obesity and related alterations could be mediated partly by programming  
a healthier composition of gut microbioma, inducted by some breast milk components  
(nondigestible oligosaccharides). 
2.4. Cancer 
Breast milk is functionally positive not only for the child but also for the mother. 
Considering the proven existence of an inversely correlation between breastfeeding duration and 
breast cancer risk [50], an important case-control study, examined the relationship between  
breast-feeding and breast cancer risk among women who carried deleterious mutations in the BRCA1 
or BRCA2 gene [51]. The results showed that women with deleterious BRCA1 mutations who  
breast-fed for a cumulative total of more than one year, presented a statistically significantly reduced 
risk of breast cancer than those who did not breast-feed their children [51]. No association were found 
between breast cancer risk and breast-feeding for women with BRCA2 mutations, probably because of 
the small size of sample. Breastfeeding may reduce the risk of breast cancer both directly by altering 
the hormonal milieu that indirectly by delaying the re-establishment of ovulation in the way to induce 
changes in mammary gland differentiation [51]. A recent study showed that in vitro DHA, a natural 
ligand of peroxisome proliferator-activated receptors, is able to modulate PPARβ mRNA expression 
inhibiting breast cancer cell growth and mammary tumor growth [52]. 
Further studies are needed to find a possible epigenetic link between human milk component and 
prevention of breast cancer. 
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3. Breast Milk and Environmental Factors: Smoking as Epigenetic Factor 
Maternal smoking during pregnancy has been associated with a reduced content of n-3 LCPUFA in 
breast milk, particularly concerning DHA, reducing the intake of these key nutrients to the infants [53]. 
The exposure to cigarette smoke may negatively affect the synthesis of n-3 LC-PUFA from the 
precursor in mammary gland cells. Indeed, in vitro studies, showed that there is a dose-dependent 
relationship between smoking and the inhibition of both the conversion of the precursor alpha-linolenic 
acid to n-3 LC-PUFA and of the D5 desaturation step [54]. 
4. Discussion 
Although the different epigenetic mechanisms involved remain unclear, the benefits of 
breastfeeding against NEC, infectious diseases, obesity and related-disorders, and cancer might be 
partly explained by the epigenetic model. Breast milk, modulating gene expression without changing 
the nucleotide sequence of DNA, might positively modify the phenotype and the outcome even if there 
is a genetic predisposition for the development of diseases. Possible epigenetic effect of human breast 
milk components on a child’s health outcomes are summarized in Table 1. However, further studies 
are warranted to provide more explanations about the direct relationship between human breast milk 
and components and gene expression, particularly regarding prevention of non-communicable disease 
in infants carrying genetic polymorphisms associated to risk of these diseases. Considering the 
important role of human milk in the development of later diseases, breastfeeding support and 
promotion should be a priority for each community. Indeed the individualized strategy according to 
nutrigenomics perspective should not distract from a global strategy. 
Table 1. Epigenetic effect of human breast milk components on the child’s health outcomes. 
Human Milk 
Component 
Prevention of Gene (Expression) 
Lactoferrin 
NEC 
Disorders of immune system 
NF-kB (reducesd) (a) 
Prostaglandin J Obesity and related-disorders PPARγ (increased) (b) 
LCPUFA n-3 
NAFLD 
liver lipogenic and cholesterol 
byosynthesis enzymes (reducesd) (a) 
Progression of NAFLD PPAR α and γ (increased) (b) 
High blood total cholesterol in adulthood HMGCoA reductase (reducesd) (a) 
Cholesterol 
content 
High blood total cholesterol in adulthood HMGCoA reductase (reducesd) (b) 
Undigestible 
oligosaccharides 
Gut dysbiosis and related alterations (NEC, 
infectious diseases, disorders of immune system, 
obesity and linked disorders) 
action on expression  
of different genes  
(e.g., NF-κB) (b) 
(a) proved in vitro and/or animals (b) hypothesized in humans. 
5. Conclusions 
The current aim of nutrigenetics is to personalize nutritional practice according to genetic variations 
that influence the way of digestion and metabolism of nutrients introduced with the diet. Nutritional 
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epigenetics concerns knowledge about the effects of nutrients on gene expression. Human breast milk 
is well-known for his properties to prevent several communicable and non-communicable diseases in 
infancy and in adult life. Breastfed children may have lower risk of NEC, infectious diseases, later 
obesity, and related disorders, and breastfeeding mothers may have lower risk of breast cancer, even if 
a genetic predisposition for the development of these diseases is present. The source of these health 
beneficial effects may be the peculiar composition of breast milk. The benefits associated to 
breastfeeding might be partly explained by epigenetic processes. However, the different epigenetic 
mechanisms involved are still unclear. Further studies are warranted to provide more explanations 
about the relationship between human breast milk and gene expression, particularly regarding 
prevention of non-communicable diseases to potentially benefit the infant’s health and his later life. 
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